The effect of peroxisome-proliferator-activated receptor-α on the activity of the cholesterol 7α-hydroxylase gene

被引:68
|
作者
Patel, DD
Knight, BL
Soutar, AK
Gibbons, GF
Wade, DP
机构
[1] Hammersmith Hosp, Ctr Clin Sci, MRC, Lipoprot Grp, London W12 0NN, England
[2] Radcliffe Infirm, Nuffield Dept Clin Med, Metab Res Lab, Oxford OX2 6HE, England
关键词
diurnal rhythm; gene promoter; PPAR alpha-null mice; transcription;
D O I
10.1042/0264-6021:3510747
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cholesterol 7 alpha -hydroxylase (Cyp7a1) plays a central role in the regulation of bile acid and cholesterol metabolism, and transcription of the gene is controlled by bile acids and hormones acting through a complex interaction with a number of potential steroid-hormone-binding sites. Transcriptional activity of the human CYP7A1 gene promoter transfected into HepG2 cells was decreased in a concentration-dependent manner by co-transfection with an expression vector for peroxisome-proliferator-activated receptor-alpha (PPAR alpha). This effect was augmented by 9-cis-retinoic acid receptor-alpha (RXR alpha) and activators of PPAR alpha to give a maximum inhibition of approx. 80 %. The region responsible for this inhibition contained a site known to bind hepatocyte nuclear factor 3 (HNF4), and mutation of this site greatly decreased the effect. Co-expression of HNF4 increased promoter activity and decreased the effect of PPAR alpha. Gel-mobility-shift assays failed to detect any binding of PPAR alpha /RXR alpha dimers to any regions of the promoter containing potential binding sites. Also the hepatic abundance of Cyp7a1 mRNA in mice in which the PPAR alpha gene was disrupted was the same as in normal mice, both during the dark phase, when the animals were feeding, and during the light phase, when mRNA abundance was greatly increased. Cholesterol feeding produced the same increase in hepatic Cyp7a1 mRNA abundance in PPAR alpha -null animals as in normals. It is concluded that, whereas PPAR alpha can affect CYP7A1 gene transcription in vitro through an indirect action, probably by competing for cofactors, this is unlikely to be a major influence on Cyp7a1 activity under normal physiological conditions.
引用
收藏
页码:747 / 753
页数:7
相关论文
共 50 条
  • [41] CIS-DICHLORODIAMMINEPLATINUM UPREGULATES THE EXPRESSION OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-γ AND ENHANCES THE CYTOTOXICITY OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-γ AGONIST
    Tanaka, Nobuyuki
    Miyajima, Akira
    Hasegawa, Masanori
    Shirotake, Suguru
    Kosaka, Takeo
    Kikuchi, Eiji
    Oya, Mototsugu
    JOURNAL OF UROLOGY, 2010, 183 (04): : E379 - E379
  • [42] Characterization of the human, mouse and rat PGC1β (peroxisome-proliferator-activated receptor-γ co-activator 1β) gene in vitro and in vivo
    Meirhaeghe, A
    Crowley, V
    Lenaghan, C
    Lelliott, C
    Green, K
    Stewart, A
    Hart, K
    Schinner, S
    Sethi, JK
    Yeo, G
    Brand, MD
    Cortright, RN
    O'Rahilly, S
    Montague, C
    Vidal-Puig, AJ
    BIOCHEMICAL JOURNAL, 2003, 373 : 155 - 165
  • [43] Role of peroxisome-proliferator-activated receptor β/δ (PPARβ/δ) in gastrointestinal tract function and disease
    Peters, Jeffrey M.
    Hollingshead, Holly E.
    Gonzalez, Frank J.
    CLINICAL SCIENCE, 2008, 115 (3-4) : 107 - 127
  • [44] Antifibrotic effect by activation of peroxisome proliferator-activated receptor-γ in corneal fibroblasts
    Pan, Hongwei
    Chen, Jiansu
    Xu, Jintang
    Chen, Miaojiao
    Ma, Rong
    MOLECULAR VISION, 2009, 15 (245): : 2279 - 2286
  • [45] The Role of epigenetic Modifications in Pre-eclampsia related to PPARγ (Peroxisome-Proliferator-activated Receptor-γ) and Galectin-2
    Meister, S.
    Hahn, L.
    Beyer, S.
    Kolben, T. M.
    Schmoeckel, E.
    Mayr, D.
    Vattai, A.
    Hester, A.
    Corradini, S.
    Hasbargen, U.
    Mahner, S.
    Jeschke, U.
    Kolben, T.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (10) : E130 - E130
  • [46] The effect of peroxisome proliferator-activated receptor-γ ligand on urological cancer cells
    Yoshimura, R
    Matsuyama, M
    Hase, T
    Tsuchida, K
    Kuratsukuri, K
    Kawahito, Y
    Sano, H
    Segawa, Y
    Nakatani, T
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2003, 12 (06) : 861 - 865
  • [47] Potentiation of liver X receptor transcriptional activity by peroxisome-proliferator-activated receptor γ co-activator 1α
    Oberkofler, H
    Schraml, E
    Krempler, F
    Patsch, W
    BIOCHEMICAL JOURNAL, 2003, 371 : 89 - 96
  • [48] Peroxisome proliferator-activated receptor-δ, a regulator of oxidative capacity, fuel switching and cholesterol transport
    C. Fürnsinn
    T. M. Willson
    B. Brunmair
    Diabetologia, 2007, 50 : 8 - 17
  • [49] The peroxisome proliferator-activated receptor-γ agonist pioglitazone represses inflammation in a peroxisome proliferator-activated receptor-α- dependent manner in vitro and in vivo in mice
    Orasanu, Gabriela
    Ziouzenkova, Ouliana
    Devchand, Pallavi R.
    Nehra, Vedika
    Hamdy, Osama
    Horton, Edward S.
    Plutzky, Jorge
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (10) : 869 - 881
  • [50] Expression of peroxisome proliferator-activated receptor-γ1 and peroxisome proliferator-activated receptor-γ2 in visceral and subcutaneous adipose tissue of obese women
    Giusti, V
    Verdumo, C
    Suter, M
    Gaillard, RC
    Burckhardt, P
    Pralong, F
    DIABETES, 2003, 52 (07) : 1673 - 1676